0.93 -0.03 (-3.12%)

99.20% Fall from 52W High

960.1K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)



Insider Trading disclosures for Allarity Therapeutics Inc

The latest disclosure was made by Joseph W. Vazzano in Allarity Therapeutics Inc where a trade of 25,000 Stock Options done was reported to US exchanges on Jan. 22, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Joseph W. Vazzano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 25,000 25,000 - - Stock Options
Thomas H. Jensen CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 396,734 396,734 - 0 Common Stock
Jeremy Graff CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 144,441 262,924 - 0 Common Stock
Laura E. Benjamin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 25,000 25,000 - - Stock Options
Alexander Epshinsky CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 29,496 85,051 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures